Skip to content
Search

Latest Stories

Mammootty starrer The Priest to release on 11th March 2021

Mammootty starrer The Priest to release on 11th March 2021

By Murtuza Iqbal

Mammootty starrer The Priest is one of the most awaited Malayalam films of the year. The movie was slated to release on 4th March 2021 but was postponed as the state government of Kerala had canceled the night shows in theatres.


However, recently, once again it was announced that the night shows will be allowed. So, the makers of The Priest decided to release the film on 11th March 2021.

Director Jofin T Chacko took to Instagram to make an announcement about it. He posted, “ഉത്തരവ് പുറത്തിറങ്ങി .. കേരളത്തിൽ സെക്കൻഡ് ഷോ അനുവദിച്ചു ☺️ പ്രീസ്റ്റ് മാർച്ച് 11 , തിയേറ്ററിൽ ..!”

A few days ago, the makers had unveiled the second teaser of the film. Mammootty had shared on Twitter.

Apart from Mammootty, the film also stars Manju Warrier in the lead role. This will be for the first time when we will get to see both the actors on the big screen together.

Talking about Mammotty’s other movies; he has a film titled One lined-up. It’s a political thriller and was slated to release in May 2020, but was postponed due to the pandemic.

Meanwhile, Manju Warrior will be seen in films like Marakkar: Arabikadalinte Simham and Jack and Jill.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less